Background The memory immune response is crucial for preventing reinfection or reducing
disease severity. However, the robustness and functionality of the humoral and T-cell …

Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …

Monitoring the humoral protective immune response and its durability after SARS-CoV-2
infections is essential for risk assessment of reinfections, the improvement of diagnostic …

Understanding the immunopathology of severe pulmonary disease and critical illness in
patients with coronavirus disease 2019 (COVID-19) is essential to the development of …

We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …

Objective The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
challenges national health systems and the global economy. Monitoring of infection rates …

Methods| Healthy adults who reported no SARS-CoV-2 vaccination were recruited via 1
public Twitter post and 1 public Facebook advertisement between September 11, 2021, and …

B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …

Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …